STOCK TITAN
  1. Home
  2. CLNNW

Clene Warrant (CLNNW) Stock Price, News & Analysis

CLNNW NASDAQ
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
97 176 sessions, December 27, 2024 to December 29, 2025
Largest daily move
+46.7% close of July 29, 2025
1-year change
-94.9% closing prices, December 27, 2024 to December 29, 2025
1-month change
-74.3% closing prices, November 26, 2025 to December 29, 2025

Company Description

Clene Warrant (NASDAQ: CLNNW) is classified in the pharmaceutical preparations industry.

CLNNW declined 94.9% in the 12 months to December 29, 2025. The last closing price was $0.0018.

For FY2025, Clene Warrant reported revenue of $200K with net income of -$26.2M.

This page collects what Stock Titan holds for CLNNW, including price data, SEC filings, financial highlights, and short interest trends.

Stock Performance

Chart
$0.0018
No recent trading
Last close: December 29, 2025
-94.9%
1 year to December 29, 2025
-
Market Cap
-
Shares outstanding

Clene Warrant (CLNNW) closed at $0.0018 on December 29, 2025. In the 12 months to December 29, 2025, the price lost 94.9%.

See what a $1,000 investment in CLNNW would be worth today

Average down calculator for CLNNW

CLNNW Metrics & Rankings

Revenue
$200.0K
#3,746
Piotroski F-Score
1/8 Partial
#7,860
December 2025
-74.3%
—
2025
-96.4%
—

Price returns through December 29, 2025. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

View All

No recent news available for CLNNW.

SEC Filings

View All

[8-K] Clene (NASDAQ: CLNN) extends convertible note maturity and adds 1M plan shares

[4] Clene (NASDAQ: CLNN) director granted 3,564 stock options at $6.81 exercise price

[4] Clene Inc. (NASDAQ: CLNN) director receives 3,658 stock options at $6.81 strike

[4] Clene (NASDAQ: CLNN) director awarded 4,361 stock options at $6.81 strike

[4] Clene Inc. (CLNN) director granted 5,159 stock options as equity compensation

[4] Clene (CLNN) director granted 4,291-share stock option package

[4] Clene (CLNN) awards director two stock option grants at $6.81

[4] Clene (NASDAQ: CLNN) director Jonathon Gay receives 3,728 stock options at $6.81

[4] Clene (CLNN) awards director two stock option grants at $6.81

[SCHEDULE 13G/A] Chidozie Ugwumba reports 9.7% stake in Clene Inc. (CLNN)

Clene Warrant has filed 10 recent SEC filings, including 8 Form 4, 1 Form 8-K, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLNNW SEC filings →

Financial Highlights

View Full Financials

Clene Warrant generated $200K in revenue in FY2025, retaining a 78.5% gross margin, operating income reached -$23.1M, and net income was -$26.2M. The company generated -$18.5M in operating cash flow. The current ratio was 0.83, measuring current assets divided by current liabilities.

$200K
Revenue (FY2025)
-$26.2M
Net Income (FY2025)
-$18.5M
Operating Cash Flow
78.5%
Gross Profit Margin
0.83
Current Ratio
$157K
Gross Profit (FY2025)

Upcoming Events

No upcoming events scheduled for CLNNW.

Short Interest History

Last 12 Months

Short interest in Clene Warrant (CLNNW) currently stands at 3.2 thousand shares, up 39.3% from the previous reporting period. Since November 2025, short interest has increased by 39.3%.

Days to Cover History

Last 12 Months

Days to cover for Clene Warrant (CLNNW) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

CLNNW Company Profile & Sector Positioning

Clene Warrant (CLNNW) and is listed on the NASDAQ.

Frequently Asked Questions

Clene Warrant (CLNNW) has no recent trading. Its last close was $0.0018 on December 29, 2025.

The FY2025 revenue of Clene Warrant (CLNNW) is $200K, from its most recent completed fiscal year.

The FY2025 net income of Clene Warrant (CLNNW) is -$26.2M, from its most recent completed fiscal year.

The operating cash flow of Clene Warrant (CLNNW) is -$18.5M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Clene Warrant (CLNNW) is 78.5% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Clene Warrant (CLNNW), current assets divided by current liabilities, was 0.83 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Clene Warrant (CLNNW) is $157K for FY2025, its most recent completed fiscal year.

The operating income of Clene Warrant (CLNNW) is -$23.1M for FY2025, its most recent completed fiscal year. Learn about operating income.